Our Products
Acxio AP 30mg is an anorectic medication containing Clobenzorex. It is specifically designed for the short-term treatment of exogenous obesity. As an "AP" (Action Prolonged) formulation, it releases the active ingredient gradually throughout the day to help control hunger and reduce caloric intake. Key Highlights: Appetite Control: Helps significantly reduce the sensation of hunger. Extended Release: Provides a sustained effect with a single daily dose. Metabolic Support: Used as an adjunct to a reduced-calorie diet and increased physical activity. Administration: Take one capsule daily, typically in the morning before breakfast. Duration: Intended for short-term use (usually not exceeding 3 months).
Acxion 30mg (Phentermine) Fast-Acting Appetite Suppressant is a potent anorectic medication containing Phentermine. It is a short-term treatment designed to kickstart weight loss in individuals with exogenous obesity. It works by stimulating the release of neurotransmitters that signal the brain to reduce hunger and increase energy expenditure. Key Highlights: Potent Appetite Control: Significantly reduces the urge to eat. Energy Boost: Helps maintain energy levels during a calorie-restricted diet. Short-Term Support: Ideal for breaking through weight loss plateaus. Administration: Take one tablet daily, preferably 30–60 minutes before breakfast. Duration: Typically prescribed for short-term use (up to 12 weeks)
Mounjaro 5mg (Tirzepatide) Metabolic Balance & Weight Support Mounjaro 5mg is the first therapeutic titration step after the initial starting dose. This weekly injection is designed to further improve glycemic control and accelerate weight loss by dual-targeting GIP and GLP-1 receptors. It effectively stabilizes blood sugar levels while significantly reducing appetite. Key Highlights: Step-Up Dose: The standard transition dose for consistent metabolic progress. Appetite Control: Helps you feel fuller longer to naturally reduce caloric intake. Proven Results: Optimized for lowering A1C and reducing body weight. Administration: Subcutaneous injection once weekly. Storage: Must be stored in the refrigerator (2°C to 8°C).
Mounjaro 10mg (Tirzepatide) Advanced Dual-Action Support is a breakthrough once-weekly injectable designed for adults with type 2 diabetes and those seeking effective weight management. The 10mg dose is a high-strength maintenance option that works by mimicking two natural hormones (GLP-1 and GIP) to regulate blood sugar, slow digestion, and reduce appetite. Key Highlights: Dual-Action: Targets two metabolic pathways for superior results. Convenience: Single-dose, easy-to-use autoinjector pen. Results: Proven to significantly lower A1C and support weight loss. Prescription & Safety Administration: Subcutaneous injection once weekly (Abdomen, thigh, or arm). Storage: Keep refrigerated between 2°C and 8°C.
Ozempic 1mg (Semaglutide) Advanced Glycemic & Weight Control. Ozempic 1mg is a higher-strength maintenance dose of Semaglutide, a GLP-1 receptor agonist. This once-weekly injection is designed for adults with type 2 diabetes to significantly lower blood sugar (A1C) and reduce the risk of major cardiovascular events. It is also widely recognized for its potent appetite-suppressing effects that support long-term weight management. Key Highlights: Cardiovascular Protection: Clinically proven to reduce heart-related risks. Steady Glucose Control: Regulates insulin secretion naturally. Effective Satiety: Slows gastric emptying, helping you feel satisfied with smaller portions. Administration: Subcutaneous injection once weekly (same day each week). Storage: Store in the refrigerator (2°C to 8°C). Once in use, the pen can be kept at room temperature for up to 56 days.
Saxenda 6mg/mL (Liraglutide) Daily Metabolic & Weight Management Saxenda is an FDA-approved, once-daily injectable medicine (GLP-1 receptor agonist) designed for chronic weight management. Unlike weekly injections, Saxenda’s daily 6mg/mL formula allows for precise dose adjustments, helping your body regulate appetite and reduce hunger signals throughout the day. Key Highlights: Daily Control: Offers a steady, consistent level of appetite suppression. Customizable Titration: The multi-dose pen allows for gradual increases to minimize side effects. Proven Efficacy: Supports significant weight loss when paired with a reduced-calorie diet. Administration: Subcutaneous injection once daily at any time, with or without food. Storage: Store unused pens in the refrigerator (2°C to 8°C). After first use, the pen can be kept at room temperature for up to 30 days.
Ozempic 2mg (Semaglutide) Maximum Strength Glycemic & Weight Support. The Ozempic 2mg/1.5mL pen is the highest available maintenance dose for Semaglutide. This once-weekly injection is specifically for those who require intensified glycemic control or have hit a plateau at lower doses. By mimicking the GLP-1 hormone, it significantly lowers A1C, provides robust cardiovascular protection, and offers the most potent appetite suppression in the Ozempic range. Key Highlights: Maximum Potency: Designed for long-term maintenance and peak metabolic efficiency. Heart Health: Clinically proven to reduce the risk of major cardiovascular events. Extended Satiety: Slows digestion to the greatest extent, helping manage caloric intake effortlessly. Administration: Subcutaneous injection once weekly (Abdomen, thigh, or upper arm). Storage: Keep refrigerated (2°C to 8°C) until first use. Once opened, store at room temperature or in the fridge for up to 56 days.
Ozempic 0.5mg (Semaglutide) Precision Glycemic & Appetite Control is the critical transition dose in the Semaglutide journey. Following the initial 0.25mg initiation phase, this strength is designed to begin active blood sugar regulation and noticeable appetite suppression. It works by mimicking the GLP-1 hormone to improve insulin sensitivity and slow gastric emptying, helping you manage weight and metabolic health effectively. Key Highlights: Active Support: The first therapeutic dose for consistent blood sugar management. Balanced Progress: Minimizes side effects while providing enhanced appetite control. Metabolic Efficiency: Supports the reduction of A1C and body weight. Administration: Subcutaneous injection once weekly (on the same day each week). Storage: Store in the refrigerator (2°C to 8°C). After first use, the pen is stable at room temperature for up to 56 days.
Zepbound 2.5mg (Tirzepatide) Starting Dose for Weight Management. Zepbound 2.5mg is the initiation dose of Tirzepatide, a dual GIP and GLP-1 receptor agonist specifically FDA-approved for chronic weight management. This starting strength is designed to introduce the medication to your system, allowing your body to acclimate to the metabolic changes while beginning to regulate hunger and fullness signals. Key Highlights: Initiation Phase: Formulated to minimize side effects during the first 4 weeks. Dual-Targeting: The only weight-loss brand that activates two separate hormone receptors. Appetite Reset: Begins the process of slowing digestion to help reduce caloric intake. Administration: Subcutaneous injection once weekly in the abdomen, thigh, or upper arm. Storage: Store in the refrigerator (2°C to 8°C). Can be kept at room temperature for up to 21 days if needed.
Wegovy 0.5mg (Semaglutide) Intermediate Dose for Sustained Weight Loss. Wegovy 0.5mg is the second step in the five-dose escalation schedule for chronic weight management. Containing Semaglutide, this once-weekly injection mimics the GLP-1 hormone to target areas of the brain that regulate appetite and food intake. This specific strength is designed to build upon the initial 0.25mg dose, further decreasing hunger and increasing feelings of fullness. Key Highlights: Escalation Phase: Designed to follow the first month of treatment to maintain weight loss momentum. Targeted Satiety: Helps significantly reduce "food noise" and cravings. Metabolic Support: Proven to assist in long-term weight reduction when paired with a healthy lifestyle. Administration: Subcutaneous injection once weekly on the same day each week. Storage: Store in the refrigerator (2°C to 8°C). Can be kept at room temperature for up to 28 days if necessary
Mounjaro 12.5mg (Tirzepatide) Advanced Strength Glycemic & Weight Control. Mounjaro 12.5mg is a high-potency maintenance dose of Tirzepatide, the only dual GIP and GLP-1 receptor agonist. This once-weekly injection is designed for individuals who have successfully titrated through lower doses and require intensified metabolic support to reach their blood sugar (A1C) and weight management goals. Key Highlights: Intensified Control: Maximum hormonal signaling for superior appetite regulation. Dual-Targeting: Actively manages insulin secretion and slows digestion. Peak Performance: Engineered for those who need more than the standard 10mg maintenance dose. Prescription & Safety Administration: Subcutaneous injection once weekly in the abdomen, thigh, or upper arm. Storage: Store in the refrigerator (2°C to 8°C). Do not freeze.
Mounjaro 2.5mg (Tirzepatide) Starting Dose for Metabolic Health is the initiation strength of Tirzepatide, a first-in-class dual GIP and GLP-1 receptor agonist. This once-weekly injection is designed to introduce the medication to your system, helping your body adjust to the dual-hormone signaling. While primarily used to start blood sugar regulation, it also begins the process of appetite suppression and digestive slowing. Key Highlights: Initiation Phase: Formulated to minimize gastrointestinal side effects during the first 4 weeks. Dual-Action Technology: Activates two separate hormone receptors for effective metabolic support. Gentle Start: Prepares the body for future therapeutic dose increases. Administration: Subcutaneous injection once weekly on the same day each week. Storage: Keep refrigerated between 2°C and 8°C. Store in the original carton to protect from light.